Daxor’s BVA-100® Published in Novel Study in American Heart Association Journal - Circulation
22 mai 2020 08h00 HE
|
Daxor Corporation
NEW YORK, May 22, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...